| breast.17 {bspmma} | R Documentation |
Aspirin and Breast Cancer: 17 studies
Description
This dataset gives log odds of breast cancer for long-term aspirin users, and its standard error, derived from 17 cohort and case-control studies.
Usage
data(breast.17)Format
A data frame with seventeen rows, corresponding to the seventeen
papers. There are two columns: psi.hat (numeric, the log odds ratio),
and se.psi.hat (numeric, estimated SE of the log odds ratio).
The rownames attribute gives the first author of the paper
and the citation number of the study in Harris et.\ al. (2005).
Source
Harris, R., Beebe-Donk, J., Doss, H., and Burr, D. (2005). “Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: A critical review of non-selective COX-2 blockade (Review).” Oncology Reports 13 559-583.
References
Gonzalez-Perez, A., Rodriguez, L., and Lopez-Ridaura, R. (2003). “Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis.” BMC Cancer 3 28.
Khuder, S. and Mutgi, A. (2001). “Breast cancer and NSAID use: a meta-analysis.” British Journal of Cancer 84, 1188–1192.